93 related articles for article (PubMed ID: 20577141)
1. Glutathione S-transferase polymorphisms in osteosarcoma patients.
Salinas-Souza C; Petrilli AS; de Toledo SR
Pharmacogenet Genomics; 2010 Aug; 20(8):507-15. PubMed ID: 20577141
[TBL] [Abstract][Full Text] [Related]
2. Significance of genetic polymorphisms in glutathione S-transferase multigene family and lung cancer risk.
Reszka E; Wasowicz W
Int J Occup Med Environ Health; 2001; 14(2):99-113. PubMed ID: 11548073
[TBL] [Abstract][Full Text] [Related]
3. Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.
Caronia D; Patiño-García A; Milne RL; Zalacain-Díez M; Pita G; Alonso MR; Moreno LT; Sierrasesumaga-Ariznabarreta L; Benítez J; González-Neira A
Pharmacogenomics J; 2009 Oct; 9(5):347-53. PubMed ID: 19434073
[TBL] [Abstract][Full Text] [Related]
4. CD86 + 1057G/A polymorphism and susceptibility to osteosarcoma.
Wang W; Song H; Liu J; Song B; Cao X
DNA Cell Biol; 2011 Nov; 30(11):925-9. PubMed ID: 21563968
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between glutathione S-transferase polymorphisms and primary glioma in a case-control study in Rio de Janeiro.
Coutinho P; Sandim V; Oliveira JA; Alves G; Hatagima A
Genet Mol Res; 2010 Mar; 9(1):539-44. PubMed ID: 20391338
[TBL] [Abstract][Full Text] [Related]
6. Single nucleotide polymorphism of pi-class glutathione s-transferase and susceptibility to endometrial carcinoma.
Chan QK; Khoo US; Ngan HY; Yang CQ; Xue WC; Chan KY; Chiu PM; Ip PP; Cheung AN
Clin Cancer Res; 2005 Apr; 11(8):2981-5. PubMed ID: 15837751
[TBL] [Abstract][Full Text] [Related]
7. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.
Sreeja L; Syamala V; Hariharan S; Syamala VS; Raveendran PB; Sivanandan CD; Madhavan J; Ankathil R
J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644
[TBL] [Abstract][Full Text] [Related]
8. Catalog of 434 single-nucleotide polymorphisms (SNPs) in genes of the alcohol dehydrogenase, glutathione S-transferase, and nicotinamide adenine dinucleotide, reduced (NADH) ubiquinone oxidoreductase families.
Iida A; Saito S; Sekine A; Kitamoto T; Kitamura Y; Mishima C; Osawa S; Kondo K; Harigae S; Nakamura Y
J Hum Genet; 2001; 46(7):385-407. PubMed ID: 11450848
[TBL] [Abstract][Full Text] [Related]
9. Predictive potential of glutathione S-transferase polymorphisms for prognosis of osteosarcoma patients on chemotherapy.
Zhang SL; Mao NF; Sun JY; Shi ZC; Wang B; Sun YJ
Asian Pac J Cancer Prev; 2012; 13(6):2705-9. PubMed ID: 22938445
[TBL] [Abstract][Full Text] [Related]
10. Glutathione S-transferase P1 genotype and prognosis in Hodgkin's lymphoma.
Hohaus S; Di Ruscio A; Di Febo A; Massini G; D'Alo' F; Guidi F; Mansueto G; Voso MT; Leone G
Clin Cancer Res; 2005 Mar; 11(6):2175-9. PubMed ID: 15788664
[TBL] [Abstract][Full Text] [Related]
11. The association between polymorphisms in glutathione S-transferase (GSTM1 and GSTT1) and lung cancer outcome.
Gonlugur U; Pinarbasi H; Gonlugur TE; Silig Y
Cancer Invest; 2006; 24(5):497-501. PubMed ID: 16939958
[TBL] [Abstract][Full Text] [Related]
12. The glutathione S-transferases: influence of polymorphism on cancer susceptibility.
Strange RC; Fryer AA
IARC Sci Publ; 1999; (148):231-49. PubMed ID: 10493261
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in miRNA processing genes and their role in osteosarcoma risk.
Bilbao-Aldaiturriaga N; Gutierrez-Camino A; Martin-Guerrero I; Pombar-Gomez M; Zalacain-Diez M; Patiño-Garcia A; Lopez-Lopez E; Garcia-Orad A
Pediatr Blood Cancer; 2015 May; 62(5):766-9. PubMed ID: 25663449
[TBL] [Abstract][Full Text] [Related]
14. Association of CYP1A1 and glutathione S-transferase polymorphisms with male factor infertility.
Aydos SE; Taspinar M; Sunguroglu A; Aydos K
Fertil Steril; 2009 Aug; 92(2):541-7. PubMed ID: 18774560
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children.
Joseph T; Kusumakumary P; Chacko P; Abraham A; Radhakrishna Pillai M
Pediatr Blood Cancer; 2004 Oct; 43(5):560-7. PubMed ID: 15382273
[TBL] [Abstract][Full Text] [Related]
16. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.
Chacko P; Joseph T; Mathew BS; Rajan B; Pillai MR
Mutat Res; 2005 Mar; 581(1-2):153-63. PubMed ID: 15725614
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia.
Canalle R; Burim RV; Tone LG; Takahashi CS
Environ Mol Mutagen; 2004; 43(2):100-9. PubMed ID: 14991750
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of cytochrome p450 2E1, glutathione S-transferase M1 and T1, and susceptibility to gastric carcinoma in Taiwan.
Wu MS; Chen CJ; Lin MT; Wang HP; Shun CT; Sheu JC; Lin JT
Int J Colorectal Dis; 2002 Sep; 17(5):338-43. PubMed ID: 12172927
[TBL] [Abstract][Full Text] [Related]
19. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance.
Hayes JD; Pulford DJ
Crit Rev Biochem Mol Biol; 1995; 30(6):445-600. PubMed ID: 8770536
[TBL] [Abstract][Full Text] [Related]
20. Additive effects of genetic variations of xenobiotic detoxification enzymes and DNA repair gene XRCC1 on the susceptibility to breast cancer.
Masoudi M; Saadat I; Omidvari S; Saadat M
Breast Cancer Res Treat; 2010 Feb; 120(1):263-5. PubMed ID: 19731014
[No Abstract] [Full Text] [Related]
[Next] [New Search]